好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Amyloid plaque burden and dual tasking impairments on the Timed up and go test in Parkinson disease
Movement Disorders
P5 - Poster Session 5 (11:45 AM-12:45 PM)
5-006

Dual tasking (DT) impairments in Parkinson disease (PD) are a correlate of fall risk. Their biological basis may reflect multiple underlying pathological causes.

Low-level amyloid-beta (Abeta) plaque burden is known to correlate with gait and cognitive impairments in PD. It is possible that Abeta plaque burden may exacerbate fall risk by worsening dual tasking cost, though this has not been evaluated to date.

In a cross-sectional cohort of 20 participants with PD, we explored the association between Abeta plaque burden and dual task cost (DTC) on the timed up and go test (TUG). TUG gait parameters were assessed using Ambulatory Parkinson’s disease monitoring (APDM) OPAL wearable sensors. Baseline TUG testing was followed by TUG testing during which the participant performed a cognitive task. DTC was calculated as the percentage difference in seconds between the two tasks. Regional Abeta plaque burden was assessed by [11C]Pittsburgh compound B (PiB) positron emission tomography (PET) imaging. Bivariate Pearson’s r statistic was calculated between DTC and PiB distribution volume ratio (DVR) in different regions of interest.

DTC during the TUG show no significant correlations with PiB DVR in the total cortical mantle (r=0.061, p=0.797), visuospatial cortex (r=0.061, p=0.798), striatum (r=0.033, p=0.890), or thalamus (r=0.041, p=0.865) but did correlate with elevated PiB DVR in the substantia nigra (r=0.535, p=0.015).

DTC in PD does not correlate with supratentorial amyloid plaque burden but may reflect mixed neurodegenerative pathology, including Abeta plaque burden, in the substantia nigra.

Authors/Disclosures
Ashley Harrie
PRESENTER
Ms. Harrie has nothing to disclose.
Benjamin Hampstead No disclosure on file
Catherine Lewis No disclosure on file
Emily Herreshoff No disclosure on file
Vikas Kotagal, MD, FAAN (University of Michigan) Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.